Market Overview

Organigram Falls Despite Q3 Revenue Growth

Share:
Organigram Falls Despite Q3 Revenue Growth

Cannabis company OrganiGram Holdings Inc. (NASDAQ: OGI) released its third-quarter financial report Monday morning.

The company disclosed third-quarter revenue of CA$24.75 million compared to $CA3.4 million in last year's quarter. This represented sales of around 3,926 kg of dried flower.

Organigram reported a quarterly net loss from continuing operations of CA$10.2 million or 7 cents per share on a diluted basis..

Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more!

Excluding the impact of non-cash fair value adjustments, the company’s third-quarter adjusted gross margin was $12.3 million or 50%, and year-to-date gross margin was $37.1 million or 58%.

“We continued to report strong sales in our third quarter and now have distribution in all ten provinces," said CEO Greg Engel. "While we saw a temporary reduction in yield per plant in Q3 due to temporary changes in growing protocols, not only have our yields returned to historical levels, but we have seen a meaningful increase in average cannabinoid levels in harvests to date in Q4."

OrganiGram's stock traded lower by 5.32% to $5.52 in Monday's pre-market session.

Never miss a news story in the cannabis world. Click here to check out Benzinga Cannabis for more.

Posted-In: Cannabis Earnings News Markets

 

Related Articles (OGI)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

AbbVie Acquires Mavupharma For Undisclosed Amount

Zosano Pharma Presents Positive Migraine-ACT Results